Login / Signup

A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.

Carter HaagAndrew AlexisValeria AokiRobert BissonnetteAndrew BlauveltRaj ChovatiyaMichael J CorkSimon G DanbyLawrence EichenfieldKilian EyerichMelinda J GooderhamEmma Guttman-YasskyDirk-Jan HijnenAlan IrvineNorito KatohDedee Frances MurrellYael A LeshemAdriane LevinIda VittrupJill I OlydamRaquel L OrfaliAmy PallerYael Renert-YuvalDavid RosmarinJonathan Ian SilverbergJacob ThyssenSonja StänderNick StefanovicGail ToddJiaDe YuEric Simpson
Published in: The British journal of dermatology (2024)
The decision to initiate a JAKinib should be shared among patient and provider, accounting for AD severity and personal risk/benefit assessment, including consideration of baseline health risk factors, monitoring requirements and treatment costs.
Keyphrases
  • atopic dermatitis
  • risk factors
  • healthcare
  • public health
  • primary care
  • mental health
  • case report
  • health information
  • decision making
  • combination therapy
  • smoking cessation
  • human health
  • clinical evaluation